Scrip
New life for ARYx's tecarfarin as US FDA approves development plans
07 January 2010
Asher Mullard
Please Login to read the full article.
07 January 2010
Asher Mullard
The US FDA has told ARYx Therapeutics that its existing development pathway is acceptable and will enable a filing of its vitamin K antagonising anticoagulant tecarfarin.
"Tecarfarin is being bought back onto the centre stage and is alive again,"
Dr Marko Kozul, an analyst at Jefferies,...
Please Login to read the full article.
RELATED CONTENT
EVENTS
Today
Berlin, Germany
Today
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
